Mild Hyperbaric Oxygen Therapy (MHBOT) enhances the body's ability to heal itself by delivering additional oxygen through a pressurized environment. Typically, oxygen transport is limited to red blood cells, but under the increased pressure of MHBOT, oxygen dissolves into the plasma and reaches further into the body's systems, including the central nervous and lymphatic systems. This process allows for improved oxygenation throughout the entire body.

MHBOT is recognized worldwide for its effectiveness in treating a wide array of conditions—over 80 in total. These range from aiding in the recovery from injuries and surgeries to treating brain and head trauma, attention deficit disorders, and PTSD, as well as various diseases and disabilities. The U.S. Food and Drug Administration (FDA) has endorsed the use of HBOT for several specific conditions. This includes issues related to cancer treatments, infections of tissues, muscles, bones, or skin, decompression sickness, poisoning, and acute conditions stemming from accidents, among others.